Institut català d'oncologia-hospital germans trias i pujol

Badalona, Barcelona 08916

0 studies enrolling now · 6 studies all time

What they study most

COVID, Gastric Cancer, Gastroesophageal Junction Cancer, HER-2 Positive Breast Cancer, Light Chain (AL) Amyloidosis, Metastatic Neoplasm, Myeloproliferative Neoplasm, Pancreatic Ductal Carcinoma, Relapsed/Refractory Diffuse Large B-cell Lymphoma

Studies at this site

• A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma — Running, not enrolling
• A Study to Evaluate the Efficacy and Safety of Birtamimab in Mayo Stage IV Patients With AL Amyloidosis — Stopped early
• Myeloproliferative Neoplasms (MPN) and COVID-19 — Completed
• Margetuximab Plus Chemotherapy vs Trastuzumab Plus Chemotherapy in the Treatment of HER2+ Metastatic Breast Cancer — Completed
• A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer — Completed
• A Study of PEGylated Recombinant Human Hyaluronidase in Combination With Nab-Paclitaxel Plus Gemcitabine Compared With Placebo Plus Nab-Paclitaxel and Gemcitabine in Participants With Hyaluronan-High Stage IV Previously Untreated Pancreatic Ductal Adenocarcinoma — Stopped early